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Abstract
Purpose—To examine associations between 22 CYP single nucleotide polymorphisms (SNPs) 
and breast cancer incidence and their interactions with grilled–smoked meat intake, a source of 
polycyclic aromatic hydrocarbons.
Methods—White women with first primary in situ or invasive breast cancer (n = 988) and 
frequency-matched controls (n = 1021) from a population-based study were interviewed to assess 
lifetime grilled–smoked meat intake. SNPs with minor allele frequencies of greater than 0.05 were 
selected because of their links to carcinogenesis. We used multivariable unconditional logistic 
regression to estimate odds ratios (ORs) and 95% confidence intervals (CIs).
Results—Breast cancer was inversely associated with CYP1A1 rs104C8943 AG + GG genotype 
(OR = 0.71, 95% CI = 0.50–0.99; vs. AA genotype) and positively associated with CYP1B1 
rs10175338 TT genotype (OR = 1.59, 95% CI = 1.12–2.26; vs. GG genotype) and the CYP3A4 
rs2242480 CT + TT genotype (OR = 1.25, 95% CI = 1.00–1.56; vs. CC genotype). The sum of the 
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number of “at-risk” alleles for the CYP SNPs was positively associated with breast cancer 
incidence (4–6 “at-risk” alleles OR = 2.33, 95% CI = 1.37–3.99 vs. 0-1 alleles; PTrend < .01). We 
observed multiplicative and additive interactions (P <.05) between grilled –smoked meat intake 
(low vs. high) with CYP1A1 rs1048943 and CYP1B1 rs10175338 SNPs.
Conclusions—Phase I metabolizing enzyme gene SNPs may play a role in breast cancer 
development and may modify the grilled–smoked meat intake–breast cancer association.
Keywords
Breast cancer; Cytochrome p450 enzymes; Polymorphism; Grilled and smoked meat; Gene–
environment interactions
Introduction
Breast cancer is the most frequently diagnosed cancer among women in the United States 
with more than 231,000 new breast cancer cases estimated in 2016 [1]. Environmental 
exposures may play a role in breast carcinogenesis [2], particularly in concert with 
polymorphic low penetrance, but common genes [3]. Exposure to polycyclic aromatic 
hydrocarbons (PAHs), a group of more than 100 different chemicals that are formed during 
the incomplete combustion of coal, oil, and gas and other organic substances like tobacco 
and are in charbroiled and/or smoked meat [4], has been associated with elevated breast 
cancer incidence [5]. During grilling and barbecuing, specifically, PAHs are generated 
through pyrolysis of meat products when fat drips from the meat onto a heated surface and 
produces smoke that coats the food with the compounds [6]. Dietary PAH exposures from 
grilled–smoked meat, the primary source of PAH exposure among nonsmokers [7], have 
been associated with breast cancer incidence, with effect estimates ranging from 1.47 to 2.21 
when comparing the highest to the lowest quantiles of intake of well-done meat [8–12].
Once ingested, PAHs induce expression of and are metabolized by phase I and phase II 
metabolizing enzymes. In phase I metabolism, PAH parent compounds are activated to 
dihydrodiol intermediates by cytochrome P450 (CYP) enzymes [13]. The dihydrodiols are 
further oxidized by CYPs into highly reactive diol epoxides, which are able to covalently 
bind to exocyclic amino groups of adenine and guanine, forming stable adducts on DNA 
[14,15]. The DNA adducts can cause mismatch in DNA replication and may alter promoter 
methylation or promoter binding, leading to inheritable DNA mutations or abnormal gene 
expression [16]. The main enzymes involved in phase I PAH metabolism include CYP1A1 
(CYP1A1 located on chromosome 15q24.1), CYP1A2 (CYP1A2 located on chromosome 
15q24.1), CYP1B1 (CYP1B1 located on chromosome 2p22.2), and CYP3A4 (CYP3A4 
located on chromosome 7q21.1), four of approximately 60 CYP enzymes [13].
CYP enzymes are primarily and abundantly expressed in the liver, kidneys, gastrointestinal 
tract, and lungs [17], but they are also expressed in normal breast tissue [18]. PAHs are 
activated and metabolized by breast epithelial cells [19], and overexpression of CYP 
enzymes and elevated levels of PAH-DNA adduct have been observed in breast tumor tissue 
[20]. Given the central role of CYP enzymes in the metabolism of xenobiotics, 
polymorphisms in CYP genes, especially those that may potentially alter the activity (e.g., 
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rs1048943, rs2472299, and rs2567206 located in promoter regions) or inducibility (e.g., 
rs1056836, rs1800440, and rs10012 located in exonic regions) relative to the common 
alleles may influence breast cancer risk [21].
In the present study, we had two study goals. First, to examine the associations between 22 
single nucleotide polymorphisms (SNPs) in four CYP enzyme genes (CYP1A1, CYP1A2, 
CYP1B1, and CYP3A4) and breast cancer incidence. Second, to examine whether the SNPs 
associated with breast cancer also modify the positive association between intake of grilled–
smoked meat and breast cancer incidence previously reported by our group [8]. We 
hypothesized that polymorphisms that lead to increased enzymatic activity and therefore 
increased production of procarcinogens would be positively associated with breast cancer 
incidence, whereas those that lead to decreased enzymatic activity would be inversely 
associated with breast cancer. We also hypothesized that high intake of grilled–smoked meat 
and SNPs that confer increased enzymatic activity would act synergistically to increase the 
risk of incident breast cancer.
Materials and methods
This study used resources from the case–control component of the Long Island Breast 
Cancer Study Project (LIBCSP), a population-based study of adult women living in Nassau 
and Suffolk Counties on Long Island, New York [22].
Study population
Details of the LIBCSP case–control participants have been previously described [22]. In 
brief, women aged older than 20 years who were residents of Nassau and Suffolk Counties 
on Long Island, New York, and who were diagnosed with invasive or in situ breast cancer in 
1996–1997 were identified using a rapid reporting system established for the LIBCSP. 
Diagnosed breast cancer cases were confirmed by each case’s physician and by medical 
record review. Of the 2271 total women identified, consent was obtained for 1837, and of 
these, 1508 (82.1%) completed the main questionnaire. Control women were residents of the 
same two Long Island counties who were frequency matched to the expected age 
distribution of the case women on 5-year age group. Control women aged 65 years and older 
were identified by Health Care Finance Administration rosters and those aged younger than 
65 years were identified by random digit dialing [23]. Of the 2714 women identified as 
potential controls, consent was obtained by 2481, and of these, 1556 (62.7%) completed the 
main questionnaire. Participants ranged in age from 20 to 95 years at diagnosis or date of 
identification for controls, and most were postmenopausal (66%) and self-identified as 
White (93%), which reflects the underlying racial distribution of these Long Island counties 
at the time of data collection.
Ethics
This study was approved by the Institutional Review Board of the University of North 
Carolina at Chapel Hill (approval no. 12-0131). Written informed consent was obtained 
from participants before data collection.
Parada et al. Page 3
Ann Epidemiol. Author manuscript; available in PMC 2017 March 24.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Assessment of dietary intake
On average, within 3 months of breast cancer diagnosis, LIBCSP participants completed an 
interviewer-administered main questionnaire and a self-administered food frequency 
questionnaire. The questionnaire elicited information on known and suspected risk factors 
for breast cancer, including reproductive, occupational, lifestyle, medical and environmental 
factors, as well as demographic characteristics. The food frequency questionnaire, which 
was completed by 98% of respondents, elicited information on approximately 100 food 
items that assessed usual diet in the previous year and was used to determine consumption of 
energy (kcal/day), fruit and vegetable intake (servings per day), and multivitamin 
supplement use (ever/never). The main questionnaire also included an assessment of intake 
of four categories of grilled–barbecued meat and smoked meat (grilled–barbecued beef, 
lamb, or pork; grilled–barbecued poultry or fish; smoked beef, lamb, or pork; and smoked 
poultry or fish) in each decade of life (<20 years, 20–29 years, 30–39 years, 40–49 years, 
50–59 years, and ≥60 years), which was used to estimate the lifetime consumption of grilled, 
barbecued, and smoked meat [8,24]. We previously reported that total intake of grilled–
smoked meat (lifetime servings) was the variable definition most strongly associated with 
breast cancer incidence [8], and thus it is the definition we use in the gene–environment 
study reported here.
SNP selection and genotyping
We selected 24 polymorphisms representing four genes of phase I metabolizing CYP 
enzymes: CYP1A1 (rs1531163, rs2472299, rs2606345, rs4646903, rs1048943, and 
rs1800031), CYP1A2 (rs2069522, rs2470890, rs2472304, and rs762551), CYP1B1 
(rs10175338, rs10175368, rs1056836, rs10916, rs162330, rs162555, rs162556, rs162557, 
rs162562, and rs1800440), and CYP3A4 (rs11773597, rs12333983, rs2242480, and 
rs2740574). The 24 polymorphisms were selected because of the documented role of the 
CYP enzymes in the activation of PAHs [13], the reported link of the SNPs to carcinogenesis 
[25], and previously reported minor allele frequencies of at least 0.05 in Caucasian women 
[25].
At the time of the interview, approximately 73% of participants provided a nonfasting blood 
sample. As previously reported [22], participants were more likely to donate blood if they 
were aged younger than 65 years, used oral contraceptives–hormone replacement, drank 
alcohol, and had ever received a mammogram, but were nonsmokers. Genomic DNA was 
extracted from the mononuclear cells in whole blood separated by Ficoll (Sigma Chemical 
Co., St. Louis, MO). CYP1A1 SNPs rs4646903, rs1048943, and rs1800031 were genotyped 
by BioServe Biotechnologies (Laurel, MD) using Sequenom’s (San Diego, CA) high-
throughput matrix-assisted laser desorption/ionization time-of-flight mass spectrometry [26]. 
The remainder of the SNPs were genotyped at the University of North Carolina at Chapel 
Hill using the Illumina GoldenGate assay (Illumina, Inc., San Diego, CA). For the latter, 
assay intensity data and genotype cluster images for all SNPs were reviewed individually 
using GenomeStudio software, v. 2011.1. Blind duplicates of 56 samples were genotyped to 
verify the reproducibility of genotype calls. Concordance between duplicates was greater 
than 99.4% for all pairs.
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Statistical analysis
This study is restricted to the 2009 women (n cases = 988 and n controls = 1021) who self-
identified as White and for whom genotyping data were available because of the small 
sample sizes in other race–ethnicity groups. We tested for Hardy–Weinberg equilibrium 
among the control women using Proc Allele on SAS/Genetics version 9.3 (Cary, NC) at an 
alpha level of 0.05. Two SNPs (rs4646903 and rs11773597) exhibited significant departure 
from Hardy–Weinberg equilibrium and were not considered further. We also examined all 
SNPs for linkage disequilibrium (LD) using the SNAP database based on HapMap [27]. The 
following pairwise SNPs were in LD: CYP1A2 rs2470890 and rs2472304; CYP1B1 
rs10175338 and rs10175368; and CYP1B1 rs10916 and rs162562. For the three pairs of 
SNPs in LD, only the results for one SNP (rs2470890, rs10175338, rs10916) are presented.
For the statistical analysis, we addressed our two study goals. First, to examine whether 22 
SNPs in four CYP genes are associated with breast cancer risk. And, second, to examine 
whether interactions between these SNPs and intake of grilled–smoked meat were associated 
with breast cancer. To address the first goal, odds ratios (ORs) and 95% confidence intervals 
(CIs) of the associations between 22 CYP genotypes and breast cancer incidence were 
estimated using unconditional logistic regression [28] in SAS version 9.4 (Cary, NC). In the 
text, we present results of dominant models; results of additive models are presented in 
Supplemental Table 1. All models were adjusted for age to account for frequency matching. 
Common homozygote genotypes defined among the control women were the referent group 
for all analyses. We created a summary SNP index for each participant by summing the 
number of “at-risk” alleles present for each SNP that was found to be associated with breast 
cancer (total of three SNPs). Based on the associations presented in Table 1, the “at-risk” 
allele was defined as the less common (variant) allele (CYP1B1 rs10175338: T allele; and 
CYP3A4 rs2242480: T allele), with the exception of the CYP1A1 rs1048943 SNP where the 
more common allele (A allele) was associated with increased risk in this population. SNPs 
that were significantly associated with breast cancer incidence were further considered as 
interactions with lifetime grilled–smoked meat intake, dichotomized at the median (high = 
4297 to 51,652 vs. low = 0 to 4296) among controls.
To address our second study goal, the interaction of CYP genotypes with intake of grilled–
smoked meat was evaluated by including cross-product terms in the logistic regression 
models. Multiplicative interactions were examined by comparing the models with the 
interaction term against a reduced model that included only terms for the main effects and 
conducting a likelihood ratio test; the results are presented by stratifying the grilled–smoked 
meat intake–breast cancer association by CYP genotype. For additive interaction, we 
explored the joint effects of lifetime grilled–smoked meat intake and CYP genotype 
(heterozygous + variant allele vs. common allele); we created three indicator variables for 
each SNP and included all three variables in a single logistic regression model. The 
following covariates were considered as potential confounders of the association between 
grilled–smoked meat intake and incident breast cancer: age, menopausal status, education, 
parity, use of hormone replacement therapy, smoking status, physical activity, body mass 
index, alcohol intake, energy intake, intake of fruits and vegetables, and single and multiple 
vitamin use [8]. Of these, the following covariates were found to change the effect estimate 
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for the association between grilled–smoked meat intake and breast cancer incidence by more 
than 10% and were included in the final multivariable models: age at diagnosis (5-year age 
groups), energy intake (continuous), fruit and vegetable intake (categorized as quintiles of 
intake in the past 12 months), and multivitamin supplement use (yes vs. no).
Results
Results corresponding to our two study goals (to determine whether breast cancer risk was 
associated with 22 SNPs in four CYP genes and the interaction between CYP SNPs and 
intake of grilled–smoked foods) are presented in the following.
CYP SNPs and breast cancer risk
The CYP1A1 rs1048943 AG + GG genotype was inversely associated with breast cancer 
incidence (OR = 0.71, 95% CI = 0.50–0.99) relative to the AA genotype, as shown in Table 
1. We observed increased ORs for the associations between breast cancer incidence and 
CYP1B1 rs10175338 TT (ORTT vs. GG = 1.59, 95% CI = 1.12–2.26), which was in LD with 
rs10175368, and CYP3A4 rs2242480 CT + TT (ORCT + TT vs. CC = 1.25, 95% CI = 1.00–
1.56). The sum of the number of “at-risk” alleles for these three CYP SNPs (rs10175338, 
rs2242480, and rs1048943) was positively associated with breast cancer incidence (PTrend 
< .01); the odds of breast cancer incidence among women with 4–6 “at-risk” alleles was 2.33 
(95% CI = 1.37–3.99) times the odds among women with 0 or 1 “at-risk” alleles.
CYP SNP interactions with grilled–smoked meat intake and breast cancer risk
We observed significant effect modification on a multiplicative scale of the association 
between total grilled–smoked meat intake over the life-course and breast cancer incidence 
by CYP1A1 rs1048943 (PInteraction = .03) and CYP1B1 rs10175338 (PInteraction < .01) SNPs 
(Table 2). Among women with the CYP1B1 rs10175338 GG genotype, the OR for the 
association with high grilled–smoked meat intake, compared with low intake, was increased 
approximately 60% (OR = 1.59, 95% CI = 1.15–2.20); but among women with the GT + TT 
genotypes and high grilled–smoked meat intake, the OR was decreased approximately 30% 
(OR = 0.71, 95% CI = 0.50–1.02). There was some suggestion of effect modification by the 
CYP3A4 rs2242480 genotype (PInteraction = .07); the OR for the grilled–smoked meat–breast 
cancer association was elevated 59% (OR = 1.59, 95% CI = 0.91–2.77) among women with 
the CT + TT genotype, but not among women with the CC genotype (OR = 1.01, 95% CI = 
0.78–1.30). In addition, as shown in Table 3, we observed effect modification on the additive 
scale for CYP1A1 rs1048943 (interaction contrast ratio = −0.82, 95% CI = −1.62 to −0.01) 
and CYP1B1 rs10175338 (interaction contrast ratio = −0.97, 95% CI = −1.72 to −0.23).
Discussion
In our population-based case-control study of 22 SNPs of four CYP genes, the variant allele 
of CYP1A1 rs1048943 was associated with a reduced OR for breast cancer, whereas the 
variant alleles of CYP1B1 rs10175338 and CYP3A4 rs2242480 were associated with an 
increased OR for breast cancer incidence. The association with breast cancer was further 
elevated in a dose-response manner when we considered the sum of the risk alleles of the 
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three SNPs. When considering effect measure modification, we observed multiplicative 
interactions between lifetime grilled–smoked meat intake with CYP1A1 rs1048943 and 
CYP1B1 rs10175338 and additive interactions for CYP1A1 rs1048943 and CYP1B1 
rs10175338.
The CYP1A1 rs1048943, an A >G transition in exon 7, leads to the substitution of 
isoleucine (Ile) for valine (Val), resulting in increased enzymatic activity [29]. This suggests 
more efficient generation of reactive PAH intermediates, and thus increased breast cancer 
risk. However, CYP1A1 also catalyzes the conversion of estradiol into noncarcinogenic 2-
hydroxyestradiol in extra-hepatic tissues, which may explain the inverse association we 
observed in this study between the CYP1A1 rs1048943 Ile/Val-genotype and breast cancer. 
Our findings are consistent with at least one other case–control study [30] of Japanese 
women in which the Ile/Val-genotype was found to be associated with reduced breast cancer 
incidence compared with the Ile/Ile genotype; however, a meta-analysis did not report 
reduced breast cancer incidence for the Ile/Val or Val/Val genotypes [31]. Prior studies also 
have not supported an association between breast cancer risk and CYP3A4 rs2242480 [32] 
and CYP1B1 rs10175368 [33,34] variants. In contrast, in this study, we report a positive 
association with the variant alleles of CYP1B1 rs10175338 and CYP3A4 rs2242480. These 
SNPS occur within the noncoding regions of CYP1B1 and CYP3A4, and the associations 
may be explained by linkage of these SNPS with other polymorphisms that have an effect on 
enzymatic function. For example, in addition to being in LD with each other, CYP1B1 
rs10175338 and rs10175368 are also in LD with CYP1B1 rs1056827 [27], located in the 
second exon of chromosome 2p21.22 that results in an amino acid change from alanine to 
serine [35]. However, it is possible that these SNPS may have functional effects as well. 
Polymorphisms in noncoding sequences may influence gene function by altering the level, 
location, stability, or timing of gene expression [36]. rs2242480, a C > T substitution in 
intron 10 of CYP3A4, significantly increases its transcription [37].
No previous studies have examined the joint effects on breast cancer risk of CYP genotype 
and grilled–smoked meat intake, an important source of PAH exposure [7]. However, the 
interaction between the CYP1A1 variants and environmental exposures has been studied in 
relation to cigarette smoking, polychlorinated biphenyls, and alcohol intake with some 
positive results [31]. For example, Ambrosone et al. found that carriers of the CYP1A1 
Ile/Val genotype versus the Ile/Ile genotype who were nonsmokers, light smokers, and heavy 
smokers had relative risks of breast cancer of 1.30 (95% CI = 0.62–2.70), 5.22 (95% CI = 
1.16–23.56), and 0.86 (95% CI = 0.24–3.09), respectively [38]. Consistent with the findings 
of an elevated risk of breast cancer among nonsmokers and light smokers with CYP variant 
alleles, we observed elevated ORs among women with the rs10175338 variant allele and 4–6 
“at-risk” alleles and low intake of grilled–smoked meats (Table 3). As is hypothesized in the 
smoking and lung cancer literature [39], this may suggest that subtle changes in enzyme 
function based on genotype are masked among those who have high levels of exposure. Our 
results reported here show that the CYP genes may act antagonistically and synergistically 
to influence breast cancer development in the presence of dietary exposures. These results 
further contribute to the growing evidence for a role of PAHs in the etiology of breast cancer 
[40].
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Our study used a large population-based case–control design to examine the genetic variants 
of the four main CYP enzymes involved in the metabolism of PAHs; however, several 
limitations should be noted. First, the large number of statistical tests could have resulted in 
spurious results. However, the associations examined here are biologically plausible as 
polymorphisms in genes encoding the CYP metabolizing enzymes are known to have the 
potential to alter enzyme activity and inducibility. In this report, we were interested 
understanding the main effects of the CYP genetic polymorphisms as well as their 
interactions with intake of grilled–smoked meat. We therefore do not present Bonferroni-
corrected results, which can be overly conservative. Second, it is possible that the 
associations observed here are confounded by other SNPs not measured in our study. This 
may be especially true for the SNPs that occur in noncoding regions. However, the SNPs 
examined in this study have been shown to impact CYP enzyme activity. Third, 
approximately, 73% of case participants and 73% of control participants provided blood 
samples for analyses resulting in a sample size of 2009 for the present study. Donation of 
biological samples varied with age with lower proportions of older women, and in particular 
older control women, donating blood [22]. It is possible that this selection could bias our 
results; however, the proportion of eligible subjects who donated blood is comparable with 
other population-based studies that collected blood [41]. Thus, LIBCSP study results are 
likely to be as representative of the general population as those from other major population-
based studies of breast cancer. Fourth, we used a self-reported measure of lifetime intake of 
grilled–smoked meat rather than an estimate of PAH intake specifically or a PAH biomarker. 
Grilling and smoking foods is well-known to increase the level of carcinogenic PAHs [7]. 
Importantly, measurement of PAH exposure by use of biomarkers reflects short-term 
exposure as adducts are excised, and DNA is repaired. Therefore, self-reported 
measurements of long-term exposure are our best alternative. Although the validity of recall 
of lifetime intake of grilled–smoked meat has not been directly examined, prior studies have 
reported modest correlations between dietary assessment at one point in time and recall of 
the same diet up to 20 years later [42,43]. Misclassification of the intake of grilled–smoked 
meat could result in bias toward or away from the null. In addition, while our categorization 
of lifetime intake of grilled–smoked meat intake at the median maximized our power to 
examine interactions and allowed us to more easily examine both multiplicative and additive 
interactions, this categorization scheme limits our ability to make clinical or public health 
recommendations regarding specific quantities in intake of grilled–smoked meat as related to 
risk of breast cancer. In a previous report where we describe our results of examining the 
intake of grilled–smoked foods in association with the risk of developing breast cancer [8], 
we considered intake at various ages and lag times. However, the strongest associations with 
breast cancer risk were with cumulative lifetime intake. Thus, for the interaction analysis, 
we a priori decided to consider lifetime intake only. Furthermore, we also decided against 
including a lag period since the main carcinogens in grilled–smoked meat, PAHs, could act 
as both initiators and promoters—several PAHs including chrysene and fluoranthene show 
estrogenic activity in vitro [44]— and so including a lag may underestimate the associations. 
Finally, it is possible that there could be differential recall of grilled– smoked meat intake by 
case–control status; however, previous studies of long-term recall of diet have not found 
differential recall between cancer cases and controls [45].
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In summary, results from our population-based study indicate that genetic variants of four 
phase I metabolizing enzyme genes may play a role in breast cancer development and may 
modify the positive association between grilled–smoked meat intake and breast cancer.
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Table 1
Age-adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for cytochrome P450 genotypes in breast 
cancer cases and controls in the Long Island Breast Cancer Study Project (n = 2009)
Gene (rs id) Cases/controls OR (95% CI)
CYP1A1 (rs1531163)
 AA 891/912 Ref.
 AG 93/106 0.87 (0.65–1.17)
 GG 1/2 0.60 (0.05–6.52)
 AG + GG 94/108 0.87 (0.64–1.16)
CYP1A1 (rs2472299)
 GG 483/515 Ref.
 GA 422/420 0.97 (0.69–1.36)
 AA 78/83 1.07 (0.89–1.29)
 GA + AA 500/503 1.06 (0.88–1.26)
CYP1A1 (rs2606345)
 AA 407/423 Ref.
 AC 437/448 1.02 (0.84–1.24)
 CC 138/149 0.98 (0.75–1.29)
 AC + CC 575/597 1.01 (0.85–1.21)
CYP1A1 (rs1048943)
 AA 873/890 Ref.
 AG 60/92 0.69 (0.49–0.97)
 GG 4/3 1.19 (0.26–5.38)
 AG + GG 64/95 0.71 (0.50–0.99)
CYP1A1 (rs1800031)
 TT 903/954 Ref.
 TC 9/5 1.97 (0.65–5.95)
 CC 1/0 —
 TC + CC 10/5 2.19 (0.74–6.49)
CYP1A2 (rs2069522)
 TT 931/963 Ref.
 TC 53/57 1.00 (0.67–1.47)
 CC 1/0 —
 TC + CC 54/57 1.02 (0.69–1.50)
CYP1A2 (rs2470890)*
 TT 371/394 Ref.
 TC 447/471 1.01 (0.84–1.23)
 CC 162/151 1.12 (0.86–1.46)
 TC + CC 609/622 1.04 (0.87–1.25)
CYP1A2 (rs762551)
 AA 471/510 Ref.
 AC 422/417 1.10 (0.91–1.32)
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Gene (rs id) Cases/controls OR (95% CI)
 CC 82/90 0.97 (0.70–1.34)
 AC + CC 504/507 1.07 (0.90–1.28)
CYP1B1 (rs10175338)*
 GG 525/564 Ref.
 GT 369/388 1.03 (0.85–1.24)
 TT 90/64 1.59 (1.12–2.26)
 GT + TT 459/452 1.11 (0.93–1.32)
CYP1B1 (rs1056836)
 CC 331/337 Ref.
 CG 469/480 0.97 (0.79–1.18)
 GG 179/201 0.88 (0.68–1.13)
 CG + GG 648/681 0.94 (0.78–1.14)
CYP1B1 (rs10916)*
 TT 629/666 Ref.
 TG 307/304 1.07 (0.88–1.30)
 GG 47/47 1.06 (0.69–1.61)
 TG + GG 354/351 1.07 (0.89–1.29)
CYP1B1 (rs162330)
 TT 290/305 Ref.
 TG 488/478 1.05 (0.85–1.29)
 GG 206/236 0.89 (0.69–1.14)
 TG + GG 694/714 1.00 (0.82–1.21)
CYP1B1 (rs162555)
 AA 618/614 Ref.
 AG 321/346 0.89 (0.73–1.07)
 GG 43/56 0.74 (0.49–1.13)
 AG + GG 364/402 0.87 (0.72–1.04)
CYP1B1 (rs162556)
 TT 297/302 Ref.
 TC 472/490 0.98 (0.80–1.21)
 CC 215/224 0.98 (0.77–1.26)
 TC + CC 687/714 0.98 (0.81–1.19)
CYP1B1 (rs162557)
 CC 610/647 Ref.
 CT 327/319 1.09 (0.90–1.33)
 TT 48/55 0.93 (0.62–1.39)
 CT + TT 375/374 1.07 (0.90–1.28)
CYP1B1 (rs1800440)
 AA 653/637 Ref.
 AG 294/338 0.84 (0.70–1.02)
 GG 36/40 0.89 (0.56–1.42)
 AG + GG 330/378 0.85 (0.71–1.02)
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Gene (rs id) Cases/controls OR (95% CI)
CYP3A4 (rs12333983)
 TT 749/798 Ref.
 TA 217/204 1.15 (0.92–1.43)
 AA 17/17 1.08 (0.54–2.15)
 TA + AA 234/221 1.14 (0.92–1.41)
CYP3A4 (rs2242480)
 CC 771/831 Ref.
 CT 199/171 1.26 (1.00–1.59)
 TT 16/15 1.13 (0.55–2.32)
 CT + TT 215/186 1.25 (1.00–1.56)
CYP3A4 (rs2740574)
 AA 894/942 Ref.
 AG 84/75 1.18 (0.85–1.63)
 GG 4/2 2.43 (0.44–13.42)
 AG + GG 88/77 1.21 (0.87–1.67)
Number of “at-risk” alleles†
 0–1 27/47 Ref.
 2–3 743/809 1.58 (0.96–2.57)
 4–6 161/121 2.33 (1.37–3.99)
Ref. = reference.
*SNPs in linkage disequilibrium rs2470890 and rs2472304; rs10175338 and rs10175368; rs10916 and rs162562.
†
The “at-risk” allele was defined as follows: rs1048943: A allele; rs10175338: T allele; rs2242480: T allele.
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Table 3
Multivariable-adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for the joint effects of total 
grilled–smoked meat intake (lifetime servings) and cytochrome P450 genotype, Long Island Breast Cancer 
Study Project (n = 2009)
Gene (rs id) Lifetime servings grilled–smoked meat* OR† (95% CI) ICR‡ (95% CI), indicating additive interaction
CYP1A1 (rs1048943)
 AA Low Ref. —
 AA High 1.22 (0.96–1.57) —
 AG + GG Low 1.15 (0.64–2.05) —
 AG + GG High 0.55 (0.30–1.03) −0.82 (−1.62 to −0.01)
CYP1B1 (rs10175338) §
 GG Low Ref. —
 GG High 1.54 (1.12–2.11) —
 GT + TT Low 1.67 (1.20–2.33) —
 GT + TT High 1.24 (0.88–1.73) −0.97 (−1.72 to −0.23)
CYP3A4 (rs2242480)
 CC Low Ref. —
 CC High 1.00 (0.78–1.30) —
 CT + TT Low 1.07 (0.72–1.60) —
 CT + TT High 1.83 (1.20–2.80) 0.75 (−0.06 to 1.57)
Number of “at-risk” alleles||
 0–3 alleles Low Ref. —
 0–3 alleles High 1.20 (0.93–1.55) —
 4–6 alleles Low 1.61 (1.03–2.53) —
 4–6 alleles High 1.49 (0.91–2.45) −0.32 (−1.33 to 0.69)
Ref. = reference.
*
Low = 0–4296 times consumed, High = 4297–51,652 times consumed.
†Adjusted for age at diagnosis, energy intake, fruit and vegetable intake, and multivitamin supplement use.
‡
Interaction contrast ratio (ICR) indicating interaction on the additive scale. In the absence of interaction, ICR = 0.
§
rs10175338 is in linkage disequilibrium with rs10175368; only the results for rs10175338 are presented.
||
The “at-risk” allele was defined as follows: CYP1A1 (rs1048943): A allele; CYP1B1 (rs10175338): T allele; CYP3A4 (rs2242480): T allele.
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